Latest Information Update: 17 Jan 2011
At a glance
- Originator Pherin Pharmaceuticals
- Mechanism of Action Testosterone antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- Preclinical Benign prostatic hyperplasia
Most Recent Events
- 17 Jan 2011 Preclinical development is ongoing in USA
- 17 Jan 2011 PH 45 is available for licensing as of 17 Jan 2011. http://www.pherin.com
- 15 Nov 2000 New profile